BioSyent (CVE:RX) Shares Cross Above 50-Day Moving Average – What’s Next?

BioSyent Inc. (CVE:RX) crossed above its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of C$14.19 and traded as high as C$14.70. BioSyent shares last traded at C$14.70, with a volume of 3,046 shares.

BioSyent Stock Up 1.4%

The stock has a market capitalization of C$166.58 million, a price-to-earnings ratio of 18.75 and a beta of 0.99. The business has a 50-day moving average of C$14.19 and a 200-day moving average of C$14.32. The company has a debt-to-equity ratio of 11.66, a quick ratio of 6.91 and a current ratio of 1.89.

Insider Buying and Selling at BioSyent

In other news, Director Seyed Ahmad Ashrafi sold 1,884 shares of the business’s stock in a transaction that occurred on Tuesday, June 30th. The shares were sold at an average price of C$14.65, for a total value of C$27,600.60. Following the sale, the director directly owned 37,261 shares of the company’s stock, valued at approximately C$545,873.65. The trade was a 4.81% decrease in their position. Insiders have sold 4,358 shares of company stock worth $63,132 in the last ninety days. 33.65% of the stock is owned by company insiders.

BioSyent Company Profile

BioSyent Inc, together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia. It offers Tibella, a hormone replacement therapy consisting of tibolone; Inofolic, a natural health product to address polycystic ovarian syndrome symptoms; RepaGyn, a vaginal suppository for the healing of the vaginal mucosa, as well as for the treatment of vaginal dryness caused by aging, menopause, stress, and chemotherapy; and Gelclair, a gel formulated to aid the pain or oral mucositis.